ѻý

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

<ѻý class="mpt-content-deck">— -- News, features, and commentary about cancer-related issues
MedpageToday
Onco Break over a computer rendering of a cancer cell.

A healthy diet in prostate cancer patients on active surveillance was associated with a . (JAMA Oncology)

Some doctors see a potential to notify women about breast density. (NBC News)

Jazz Pharmaceuticals announced that adding lurbinectedin (Zepzelca) to atezolizumab (Tecentriq) as first-line maintenance therapy for extensive-stage small cell lung cancer in a phase III trial.

The FDA approved a wearable for concurrent use with a PD-1/PD-L1 inhibitor or docetaxel in patients with metastatic non-small cell lung cancer (NSCLC) who progressed on a platinum-based regimen, Novocure announced.

CDK4/6 inhibitor palbociclib (Ibrance) may be characterized by GNAS mutations, a small study indicated. (Journal of Clinical Oncology)

A helmet that applies pressure across the entire scalp could help . (CNN)

Radon exposure was linked with a higher . (Science of the Total Environment)

What can be done about the ? (CNBC)

More and more breast cancer survivors are finding that their desire to after mastectomy is being met by resistance from their doctors. (Cosmopolitan)

Sam Yoon, MD, Columbia University's chief of surgical oncology, had over suspicious results. (New York Times)

Aura Biosciences said an ongoing phase I trial of belzupacap sarotalocan (AU-011) , including complete responses in four of five patients with low-grade disease who received the virus-like drug conjugate with light activation.

  • author['full_name']

    Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.